Search by Drug Name or NDC
NDC 70069-0141-01 Cisatracurium Besylate 2 mg/mL Details
Cisatracurium Besylate 2 mg/mL
Cisatracurium Besylate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is CISATRACURIUM BESYLATE.
Product Information
| NDC | 70069-0141 |
|---|---|
| Product ID | 70069-141_757aedc0-ad65-446a-81ed-09afbe8cc595 |
| Associated GPIs | 74200013102014 |
| GCN Sequence Number | 024614 |
| GCN Sequence Number Description | cisatracurium besylate VIAL 2 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 32771 |
| HICL Sequence Number | 010278 |
| HICL Sequence Number Description | CISATRACURIUM BESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Cisatracurium Besylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cisatracurium Besylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | CISATRACURIUM BESYLATE |
| Labeler Name | Somerset Therapeutics, LLC |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206791 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70069-0141-01 (70069014101)
| NDC Package Code | 70069-141-01 |
|---|---|
| Billing NDC | 70069014101 |
| Package | 1 VIAL in 1 CARTON (70069-141-01) / 5 mL in 1 VIAL |
| Marketing Start Date | 2019-02-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |